ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Exosomes derived from PC-3 cells suppress osteoclast differentiation by downregulating miR-148a and blocking the PI3K/AKT/mTOR pathway

Tian, Gaoqiang; Hu, Konghe; Qiu, Sujun; Xie, Yingming; Cao, Yanlin; Ni, Songjia*; Zhang, Lifang*南方医科大学; 汕头大学
Experimental and Therapeutic Medicine2021-11DOI: 10.3892/etm.2021.10739
2被引6阅读
引用收藏
分享

摘要

Prostate cancer is a leading malignancy in men that can also disrupt the bone tissue balance. Among all urological cancers, prostate cancer is associated with the highest rate of bone metastases, which can greatly reduce a patient's quality of life. In recent years, cell-derived exosomes, which can contain a wide range of biologically active molecules, have been reported as a novel method of communication among individual cells. However, the specific role that exosomes serve in this disease has not been fully elucidated. The prostate cancer cell line PC-3 were applied in the present study, where its exosomes were isolated to explore their potential effects on osteoclast differentiation. Exosomes are extracellular vesicles secreted by cells. The size of exosomes is 30-150 nm. They have double membrane structure and saucer-like morphology. They contain rich contents (including nucleic acid, protein and lipid) and participate in molecular transmission between cells. The combined results of tartrate-resistant acid phosphatase staining (to identify osteoclasts obtained from human peripheral blood mononuclear cells), reverse transcription-quantitative PCR and western blotting showed that PC-3-derived exosomes attenuated osteoclast differentiation by downregulating marker genes associated with osteoclastic maturation, including V-maf musculoaponeurotic fibrosarcoma oncogene homolog B, matrix metalloproteinase 9 and integrin beta 3. microRNA (miR)-148a expression was also found to be downregulated in osteoclasts by PC-3-derived exosomes. In addition, the mTOR and AKT signaling pathways were blocked after exposure to these PC-3 cell-derived exosomes. Therefore, results from the present study suggest that miR-148a mimics may be a new therapeutic approach for the prevention of prostate cancer bone metastases.

学科与关键词

关键词
osteoclastexosomeprostate cancerPC-3 cellsmicroRNA-148a
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Experimental and Therapeutic Medicine
发表日期
2021-11
卷期
第 22 卷, 第 5 期
页码
1304
DOI
10.3892/etm.2021.10739
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81672140]; Natural Science Foundation of Guangdong Province, China [2018A030313500, 2017A030313111]

作者

  • T

    Tian, Gaoqiang (第一作者)

    shantou univ

  • H

    Hu, Konghe

    shantou univ

查看全部 7 位作者收起作者
  • Q

    Qiu, Sujun

    2 · southern med univ

  • X

    Xie, Yingming

    2 · southern med univ

  • C

    Cao, Yanlin

    2 · southern med univ

  • N

    Ni, Songjia (通讯)

    2 · southern med univ

  • Z

    Zhang, Lifang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417